Hongming Chen is an American chemical engineer.
Chen earned a Bachelor's of Science degree in chemical engineering from the University of Texas at Austin in 1992, and completed a Master's and Doctor of Science in the same subject at the Massachusetts Institute of Technology. She then conducted research at Merck & Co. and AstraZeneca. She later helped establish TransForm Pharmaceuticals, which was later acquired by Johnson & Johnson, and subsequently worked for Kala Pharmaceuticals from its founding in 2010, then cofounded Metis Therapeutics.
In 2015, Chen was elected a fellow of the American Institute for Medical and Biological Engineering. She was elected to membership of the United States National Academy of Engineering in 2018.
References
Living people
Year of birth missing (living people) 21st-century American engineers 20th-century American engineers American women engineers American chemical engineers Massachusetts Institute of Technology alumni University of Texas at Austin alumni Members of the United States National Academy of Engineering Fellows of the American Institute for Medical and Biological Engineering AstraZeneca people Merck & Co. people Janssen Pharmaceutica people